Universal-Beteiligungs- und Servicegesellschaft’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,251
Closed -$1.48M 2133
2025
Q1
$1.48M Sell
11,251
-83,949
-88% -$10.5M ﹤0.01% 1331
2024
Q4
$7.95M Buy
+95,200
New +$7.82M 0.02% 597

Other funds holding ITCI

Universal-Beteiligungs- und Servicegesellschaft's ITCI Position: Q2 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 11,251 shares — an estimated $1.48M sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $7.95M in Q4 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 11,251 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.48M.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
  • Universal-Beteiligungs- und Servicegesellschaft's Intra-Cellular Therapies Inc. position peaked at $7.95M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2025, filed 11 Aug 2025.